Archive

Seminar by Dr Bruce Conway at the Nencki Institute

07.03.2014

Dr Bruce Conway is biologist and pharmacologist with over 18 years of experience in both large and small pharmaceutical organizations. While at Johnson & Johnson, Bruce served as the project championed the progression of four compounds into the clinic, one of which resulted in Invokana/Canagliflozin as an approved treatment for Type 2 Diabetes. As the Senior Director of Biology and Pharmacology at the Institutes for Pharmaceutical Discovery, Bruce oversaw the scientific operations of ...

2014 World Brain Awareness Week in Warsaw

04.03.2014

The list of events organized this year during Warsaw Brain Awareness Week includes open lectures at POLITYKA as well as workshops and shows dedicated to secondary school and university students ...

Nencki Institute among the leaders of basic research

28.02.2014

Ranking list was published on the NSC page (in Polish): http://www.ncn.gov.pl/finansowanie-nauki/statystyki/rankingi-2013

Enhancing Proprioceptive Input to Motoneurons Differentially Affects Expression of Neurotrophin 3 and Brain-Derived Neurotrophic Factor in Rat Hoffmann-Reflex Circuitry

03.02.2014

The importance of neurotrophin 3 (NT-3) for motor control prompted us to ask the question whether direct electrical stimulation of low-threshold muscle afferents, strengthening the proprioceptive ...

CD14 Mediates Binding of High Doses of LPS but Is Dispensable for TNF- Production

03.02.2014

Lipopolysaccharide is a component of Gram-negative bacteria which strongly activates macrophages inducing production of pro-inflammatory cytokines, like TNF-. This reaction is initiated by ...